imlygic
Generic: talimogene laherparepvec
Labeler: amgen incDrug Facts
Product Profile
Brand Name
imlygic
Generic Name
talimogene laherparepvec
Labeler
amgen inc
Dosage Form
INJECTION, SUSPENSION
Routes
Active Ingredients
talimogene laherparepvec 1000000 [PFU]/mL
Manufacturer
Identifiers & Regulatory
Product NDC
55513-078
Product ID
55513-078_4d1843a8-7a83-4062-ba8c-4f97e2f1427b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA125518
Listing Expiration
2026-12-31
Marketing Start
2015-11-02
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
55513078
Hyphenated Format
55513-078
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
imlygic (source: ndc)
Generic Name
talimogene laherparepvec (source: ndc)
Application Number
BLA125518 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1000000 [PFU]/mL
Packaging
- 1 VIAL in 1 CARTON (55513-078-01) / 1 mL in 1 VIAL
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRALESIONAL"], "spl_id": "4d1843a8-7a83-4062-ba8c-4f97e2f1427b", "openfda": {"upc": ["0355513079013", "0355513078016"], "unii": ["07730V90L6"], "rxcui": ["1721278", "1721283", "1721287", "1721289"], "spl_set_id": ["64ffb680-ea8c-42fc-9649-9e8c0eb77ddb"], "manufacturer_name": ["Amgen Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (55513-078-01) / 1 mL in 1 VIAL", "package_ndc": "55513-078-01", "marketing_start_date": "20151102"}], "brand_name": "Imlygic", "product_id": "55513-078_4d1843a8-7a83-4062-ba8c-4f97e2f1427b", "dosage_form": "INJECTION, SUSPENSION", "product_ndc": "55513-078", "generic_name": "talimogene laherparepvec", "labeler_name": "Amgen Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Imlygic", "active_ingredients": [{"name": "TALIMOGENE LAHERPAREPVEC", "strength": "1000000 [PFU]/mL"}], "application_number": "BLA125518", "marketing_category": "BLA", "marketing_start_date": "20151102", "listing_expiration_date": "20261231"}